BioShares Biotechnology Historical Price Analysis

BioShares Biotechnology Clinical Trials -- USA Etf  

USD 30.95  0.001  0.0032%

Use BioShares Biotechnology Clinical Trials Historical Price Analysis together with your etf portfolios to enhance returns of your portfolios and to determine Etf optimization strategy that fits your criteria.  
 Time Horizon     30 Days    Login   to change

Performance History


Highest PriceJanuary 12, 201830.949
Lowest PricDecember 20, 201727.3899
The price series of BioShares Biotechnology for the period between Sun, Dec 17, 2017 and Tue, Jan 16, 2018 has a statistical range of 3.71 with a coefficient of variation of 3.98. The prices are distributed with arithmetic mean of 28.66. The median price for the last 30 days is 28.64
OpenHighLowCloseVolume
01/16/2018 30.68  31  30.56  30.95  11,208 
01/12/2018 30.68  31  30.56  30.95  11,208 
01/11/2018 30.25  30.64  30.1  30.51  17,555 
01/10/2018 29.5  30.13  29.2  30.12  9,972 
01/09/2018 28.7  29.46  28.7  29.46  10,427 
01/08/2018 29.44  29.49  28.45  28.73  27,527 
01/05/2018 30.19  30.19  29.25  29.32  23,091 
01/04/2018 29.73  30.02  29.39  29.85  15,874 
01/03/2018 29.55  30  29.43  29.88  18,125 
01/02/2018 28.59  29.35  28.59  29.31  14,999 
12/29/2017 28.9  29.19  28.42  28.43  16,311 
12/28/2017 28.8  28.88  28.58  28.7  16,654 
12/27/2017 28.53  28.84  28.53  28.64  12,284 
12/26/2017 28.39  28.61  28.24  28.55  5,352 
12/22/2017 28.41  28.42  27.7  28.39  32,699 
12/21/2017 27.66  27.81  27.46  27.62  10,677 
12/20/2017 27.24  27.39  27.17  27.39  1,428 

Did you try this?

Run Idea Breakdown Now
   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaixs investment ideas are predefined, sector-focused investing themes
Hide  View All  NextLaunch Idea Breakdown

Net Asset

BioShares Biotechnology Net Asset Analysis
BioShares Biotechnology Clinical Trials is rated below average in net asset as compared to similar ETFs. Total Asset Under Management (AUM) of Health category is currently estimated at about 3.87 Billion. BioShares Biotechnology maintains roughly 31.18 Million in net asset contributing less than 1% to all ETFs under Health category.